Company · CIK 0001800315
Damora Therapeutics, Inc.
DMRASearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$21.08+$0.52 (+2.53%)
DMRA · Last trade
- Prev close
- $20.56
- Range (29d)
- $19.55 – $28.39
On the record
Recent filings
- 10-QDMRAQuarterly update0001193125-26-342307 · 12.5 MBSEC(opens sec.gov)
- 144DMRADamora Therapeutics, Inc.0001970051-26-000018 · 6.4 KBSEC(opens sec.gov)
- SCHEDULE 13GDMRADamora Therapeutics, Inc.0002012383-26-002507 · 11.1 KBSEC(opens sec.gov)
- 8-KDMRACurrent report0001193125-26-308899 · 1.2 MBSEC(opens sec.gov)
- 8-KDMRACurrent report0001193125-26-274093 · 212.5 KBSEC(opens sec.gov)
- 10-QDMRAQuarterly update0001193125-26-219327 · 9.2 MBSEC(opens sec.gov)
- 8-KDMRACurrent report0001193125-26-203913 · 183.3 KBSEC(opens sec.gov)
- 8-KDMRACurrent report0001193125-26-163909 · 197.3 KBSEC(opens sec.gov)
- 8-KDMRACurrent report0001193125-26-118699 · 521.9 KBSEC(opens sec.gov)
- 10-KDMRAAnnual report0001193125-26-115922 · 16.0 MBSEC(opens sec.gov)
Insiders
- Bruno JulianneDirector
- Burkavage BrianSVP, Finance
- CAIN CHRISTOPHER W.Director
- Cheng AndrewDirector
- Christgau StephanDirector
- Dallas Jayson Donald AlexanderDirector
- Fairmount Funds Management LLCDirector, 10% Owner
- Fairmount Healthcare Fund II L.P.Director, 10% Owner
- Firmani LoriChief Financial Officer
- Freve JonathanChief Financial Officer
Tickers
Addresses
business
221 CRESCENT STREET BUILDING 23, SUITE 105
WALTHAM, MA, 02453
mailing
221 CRESCENT STREET BUILDING 23, SUITE 105
WALTHAM, MA, 02453
Former names
- Galecto, Inc.2026-03-10
- Galecto Inc.2020-10-28
Same industry